MYC and breast carcinoma: Abnormal expression of c-MYC has been found in most malignant tumors, including breast cancer, colon cancer, cervical cancer, myeloid leukemia, melanoma, osteosarcoma, glioblastoma, small-cell lung cancer, and medulloblastoma [13].